Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding

Free Radical Biology and Medicine

Volumn 61, Issue , 2013, Pages 85-94

  More, Vijay R ^a   Xu, Jialin ^a   Shimpi, Prajakta C ^a   Belgrave, Clyde ^b   Luyendyk, James P ^c   Yamamoto, Masayuki ^d   Slitt, Angela L ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Free radicals; Keap1; Metabolic syndrome; Nrf2; Steatosis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; CD36 ANTIGEN; FATTY ACID BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE SILENCING; GLUCOSE HOMEOSTASIS; INFLAMMATION; LIPID DIET; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

MUS;

EID: 84877046011     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.03.007     Document Type: Article

References (49)

1. S.M. Haffner Relationship of metabolic risk factors and development of cardiovascular disease and diabetes Obesity (Silver Spring) 14 Suppl. 3 2006 121 S 127S
2. Ervin, R. B. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. In National Health Statistics Reports, No. 13. Hyattsville, MD: National Center for Health Statistics; 2009.
3. V.O. Tkachev, E.B. Menshchikova, and N.K. Zenkov Mechanism of the Nrf2/Keap1/ARE signaling system Biochemistry (Moscow) 76 2011 407 422
4. K.C. Wu, J.Y. Cui, and C.D. Klaassen Beneficial role of Nrf2 in regulating NADPH generation and consumption Toxicol. Sci. 123 2011 590 600
5. C.D. Klaassen, and S.A. Reisman Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver Toxicol. Appl. Pharmacol. 244 2010 57 65
6. S.A. Reisman, D.B. Buckley, Y. Tanaka, and C.D. Klaassen CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes Toxicol. Appl. Pharmacol. 236 2009 109 114
7. J. Lamle, S. Marhenke, J. Borlak, R. von Wasielewski, C.J. Eriksson, R. Geffers, M.P. Manns, M. Yamamoto, and A. Vogel Nuclear factor-erythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury Gastroenterology 134 2008 1159 1168
8. K. Okada, E. Warabi, H. Sugimoto, M. Horie, K. Tokushige, T. Ueda, N. Harada, K. Taguchi, E. Hashimoto, K. Itoh, T. Ishii, H. Utsunomiya, M. Yamamoto, and J. Shoda Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis J. Gastroenterol. 47 2012 924 935
9. K.C. Wu, Y. Zhang, and C.D. Klaassen Nrf2 protects against diquat-induced liver and lung injury Free Radic. Res. 46 2012 1220 1229
10. K.C. Wu, J.J. Liu, and C.D. Klaassen Nrf2 activation prevents cadmium-induced acute liver injury Toxicol. Appl. Pharmacol. 263 2012 14 20
11. Q.Q. Tang, T.C. Otto, and M.D. Lane CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis Proc. Natl. Acad. Sci. USA 100 2003 850 855 (Pubitemid 36183919)
12. A. Koppen, and E. Kalkhoven Brown vs white adipocytes: the PPARgamma coregulator story FEBS Lett. 584 2010 3250 3259
13. J.D. Horton, J.L. Goldstein, and M.S. Brown SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 109 2002 1125 1131 (Pubitemid 34496588)
14. J.R. Mead, S.A. Irvine, and D.P. Ramji Lipoprotein lipase: structure, function, regulation, and role in disease J. Mol. Med. (Berlin) 80 2002 753 769 (Pubitemid 35478124)
15. Y.H. Lee, F. Magkos, C.S. Mantzoros, and E.S. Kang Effects of leptin and adiponectin on pancreatic beta-cell function Metabolism 60 2011 1664 1672
16. A. Chawla, K.D. Nguyen, and Y.P. Goh Macrophage-mediated inflammation in metabolic disease Nat. Rev. Immunol. 11 2011 738 749
17. G. Chinetti-Gbaguidi, and B. Staels Macrophage polarization in metabolic disorders: functions and regulation Curr. Opin. Lipidol. 22 2011 365 372
18. J. Pi, L. Leung, P. Xue, W. Wang, Y. Hou, D. Liu, E. Yehuda-Shnaidman, C. Lee, J. Lau, T.W. Kurtz, and J.Y. Chan Deficiency in the nuclear factor E2-related factor 2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity J. Biol. Chem. 285 2010 9292 9300
19. J. Huang, I. Tabbi-Anneni, V. Gunda, and L. Wang Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism Am. J. Physiol. Gastrointest. Liver Physiol. 299 2010 G1211 1221
20. J. Xu, S.R. Kulkarni, A.C. Donepudi, V.R. More, and A.L. Slitt Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice Diabetes 61 2012 3208 3218
21. H.Y. Kay, W.D. Kim, S.J. Hwang, H.S. Choi, R.K. Gilroy, Y.J. Wan, and S.G. Kim Nrf2 inhibits LXRalpha-dependent hepatic lipogenesis by competing with FXR for acetylase binding Antioxid. Redox Signaling 15 2011 2135 2146
22. S.A. Reisman, R.L. Yeager, M. Yamamoto, and C.D. Klaassen Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species Toxicol. Sci 108 2009 35 47
23. K. Taguchi, J.M. Maher, T. Suzuki, Y. Kawatani, H. Motohashi, and M. Yamamoto Genetic analysis of cytoprotective functions supported by graded expression of Keap1 Mol. Cell. Biol. 30 2010 3016 3026
24. M.S. Yates, Q.T. Tran, P.M. Dolan, W.O. Osburn, S. Shin, C.C. McCulloch, J.B. Silkworth, K. Taguchi, M. Yamamoto, C.R. Williams, K.T. Liby, M.B. Sporn, T.R. Sutter, and T.W. Kensler Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice Carcinogenesis 30 2009 1024 1031
25. J. Xu, S.R. Kulkarni, L. Li, and A.L. Slitt UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis Drug Metab. Dispos. 40 2012 259 266
26. K.M. Kassel, B.P. Sullivan, W. Cui, B.L. Copple, and J.P. Luyendyk Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease Am. J. Pathol. 181 2012 1287 1295
27. V.R. More, and A.L. Slitt Alteration of hepatic but not renal transporter expression in diet-induced obese mice Drug Metab. Dispos. 39 2011 992 999
28. V.R. More, X. Wen, P.E. Thomas, L.M. Aleksunes, and A.L. Slitt Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice Comp. Hepatol 11 2012 1
29. D.P. Hartley, and C.D. Klaassen Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology Drug Metab. Dispos 28 2000 608 616 (Pubitemid 30238522)
30. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796 1808 (Pubitemid 38063703)
31. S.E. Kahn, R.L. Hull, and K.M. Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 2006 840 846 (Pubitemid 46024990)
32. D.V. Chartoumpekis, P.G. Ziros, A.I. Psyrogiannis, A.G. Papavassiliou, V.E. Kyriazopoulou, G.P. Sykiotis, and I.G. Habeos Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice Diabetes 60 2011 2465 2473
33. J. Xu, S. Kulkarni, A. Donepudi, V.R. More, and A.L. Slitt Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice Diabetes 61 2012 1 11
34. Y.K. Zhang, K.C. Wu, J. Liu, and C.D. Klaassen Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet Toxicol. Appl. Pharmacol. 264 2012 305 314
35. Z. Yu, W. Shao, Y. Chiang, W. Foltz, Z. Zhang, W. Ling, I.G. Fantus, and T. Jin Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected] (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6 J mice Diabetologia 54 2011 922 934
36. S. Shin, J. Wakabayashi, M.S. Yates, N. Wakabayashi, P.M. Dolan, S. Aja, K.T. Liby, M.B. Sporn, M. Yamamoto, and T.W. Kensler Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide Eur. J. Pharmacol. 620 2009 138 144
37. A. Piton, C. Rauch, S. Langouet, A. Guillouzo, and F. Morel Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes Toxicol. In Vitro 24 2010 452 459
38. A. Zorzano, M. Palacin, and A. Guma Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle Acta Physiol. Scand. 183 2005 43 58 (Pubitemid 40188035)
39. X.J. Sun, P. Rothenberg, C.R. Kahn, J.M. Backer, E. Araki, P.A. Wilden, D.A. Cahill, B.J. Goldstein, and M.F. White Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein Nature 352 1991 73 77 (Pubitemid 21896701)
40. N. Halberg, I. Wernstedt-Asterholm, and P.E. Scherer The adipocyte as an endocrine cell Endocrinol. Metab. Clin. North Am. 37 2008 753 768 x-xi
41. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, and H. Chen Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest. 112 2003 1821 1830 (Pubitemid 38063705)
42. J.R. Greenfield, and L.V. Campbell Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr. Diabetes Rev. 2 2006 195 211 (Pubitemid 44082940)
43. P. Iozzo Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue Diabetes Care 32 Suppl. 2 2009 S168 173
44. R. Zhao, Y. Hou, Q. Zhang, C.G. Woods, P. Xue, J. Fu, K. Yarborough, D. Guan, M.E. Andersen, and J. Pi Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes Environ. Health Perspect. 120 2012 583 589
45. M. Kwong, Y.W. Kan, and J.Y. Chan The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents: role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts J. Biol. Chem 274 1999 37491 37498
46. M. Biswas, and J.Y. Chan Role of Nrf1 in antioxidant response element-mediated gene expression and beyond Toxicol. Appl. Pharmacol. 244 2010 16 20
47. A. Kobayashi, T. Ohta, and M. Yamamoto Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes Methods Enzymol 378 2004 273 286
48. K.J. Chandler, M. Barrier, S. Jeffay, H.P. Nichols, N.C. Kleinstreuer, A.V. Singh, D.M. Reif, N.S. Sipes, R.S. Judson, D.J. Dix, R. Kavlock, E.S. Hunter 3rd, and T.B. Knudsen Evaluation of 309 environmental chemicals using a mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay PLoS One 6 2011 e18540
49. A. Marmugi, S. Ducheix, F. Lasserre, A. Polizzi, A. Paris, N. Priymenko, J. Bertrand-Michel, T. Pineau, H. Guillou, P.G. Martin, and L. Mselli-Lakhal Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver Hepatology 55 2012 395 407